Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 156.25 | 92.36 | 100.00 | 112.50 | 0.8889 | 0.3221 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 156.25 | 92.36 | 124.00 | 112.50 | 1.1022 | 1.8157 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 156.25 | 92.36 | 89.00 | 112.50 | 0.7911 | -0.1222 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 156.25 | 92.36 | 63.00 | 112.50 | 0.5600 | -0.7394 |
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 123.00 | 112.50 | 1.0933 | 1.7367 | |
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 65.00 | 112.50 | 0.5778 | -0.7091 | |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 156.25 | 92.36 | 87.00 | 112.50 | 0.7733 | -0.1896 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 156.25 | 92.36 | 87.00 | 112.50 | 0.7733 | -0.1896 |
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 136.00 | 112.50 | 1.2089 | 2.8957 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 156.25 | 92.36 | 94.00 | 112.50 | 0.8356 | 0.0637 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 156.25 | 92.36 | 155.00 | 112.50 | 1.3778 | 5.1686 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 156.25 | 92.36 | 74.00 | 112.50 | 0.6578 | -0.5412 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 156.25 | 92.36 | 46.00 | 112.50 | 0.4089 | -0.9137 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 156.25 | 92.36 | 91.00 | 112.50 | 0.8089 | -0.0509 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 156.25 | 92.36 | 160.00 | 112.50 | 1.4222 | 5.8968 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 156.25 | 92.36 | 100.00 | 112.50 | 0.8889 | 0.3221 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 156.25 | 92.36 | 224.00 | 112.50 | 1.9911 | 21.5024 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 156.25 | 92.36 | 56.00 | 112.50 | 0.4978 | -0.8277 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 156.25 | 92.36 | 123.00 | 112.50 | 1.0933 | 1.7367 |
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 112.00 | 112.50 | 0.9956 | 0.9689 | |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 156.25 | 92.36 | 89.00 | 112.50 | 0.7911 | -0.1222 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 156.25 | 92.36 | 47.00 | 112.50 | 0.4178 | -0.9069 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 156.25 | 92.36 | 89.00 | 112.50 | 0.7911 | -0.1222 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 156.25 | 92.36 | 105.00 | 112.50 | 0.9333 | 0.5694 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 156.25 | 92.36 | 129.00 | 112.50 | 1.1467 | 2.2354 |